Clozapine is not the end of the story

Lawrence H. Price M.D.
{"title":"Clozapine is not the end of the story","authors":"Lawrence H. Price M.D.","doi":"10.1002/pu.31134","DOIUrl":null,"url":null,"abstract":"<p>As most <i>Update</i> readers are aware, the U.S. Food and Drug Administration (FDA) has approved only one drug with an indication for treatment-resistant schizophrenia: clozapine. You might not know the backstory to this though.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-01-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Brown University Psychopharmacology Update","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/pu.31134","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

As most Update readers are aware, the U.S. Food and Drug Administration (FDA) has approved only one drug with an indication for treatment-resistant schizophrenia: clozapine. You might not know the backstory to this though.

氯氮平不是故事的终结
大多数《最新消息》的读者都知道,美国食品和药物管理局(FDA)只批准了一种适用于耐药性精神分裂症的药物:氯氮平。但您可能不知道这背后的故事。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信